Cited by 65Yersinia bacterium, plague, ectoparasites researchBacillus and Francisella bacterial researchBacterial Infections and Vaccines

Hereditary Hemochromatosis Restores the Virulence of Plague Vaccine Strains

Open access
Quenee, L. E., Hermanas, T. M., Ciletti, N., Louvel, H., Miller, N. C., Elli, D., Blaylock, B., Mitchell, A. +4 more·2012·Journal of Infectious Diseases

Abstract

Nonpigmented Yersinia pestis (pgm) strains are defective in scavenging host iron and have been used in live-attenuated vaccines to combat plague epidemics. Recently, a Y. pestis pgm strain was isolated from a researcher with hereditary hemochromatosis who died from laboratory-acquired plague. We used hemojuvelin-knockout (Hjv(-/-)) mice to examine whether iron-storage disease restores the virulence defects of nonpigmented Y. pestis. Unlike wild-type mice, Hjv(-/-) mice developed lethal plague when challenged with Y. pestis pgm strains. Immunization of Hjv(-/-) mice with a subunit vaccine that blocks Y. pestis type III secretion generated protection against plague. Thus, individuals with hereditary hemochromatosis may be protected with subunit vaccines but should not be exposed to live-attenuated plague vaccines.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/infdis/jis433

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Hepcidin-deficient mice are more susceptible than wild-type mice to death from infection with Y. enterocolitica and certain attenuated strains of Y. pestis.

    “Hepcidin-deficient mice are also much more susceptible than wild-type mice to death from infection with Y. enterocolitica (D. Stefanova, Y. Bulut, T.G. and E.N., unpublished observations) and certain attenuated strains of Y. pestis47.”

    From Iron homeostasis in host defence and inflammation (2015) · cites this paper as [47]

  • Pathogenicity of Y. pestis strains lacking yersiniabactin is greatly enhanced in haemochromatotic mice generated by disruption of hepcidin or haemojuvelin.

    “The pathogenicity of similar strains was greatly enhanced in haemochromatotic mice that were generated by disruption of the gene encoding either hepcidin or its essential regulator haemojuvelin47.”

    From Iron homeostasis in host defence and inflammation (2015) · cites this paper as [47]

  • People with hereditary hemochromatosis are highly susceptible to normally noninvasive microbes such as Vibrio vulnificus and Yersinia enterocolitica.

    “individuals with HH are highly susceptible to infection by normally noninvasive microbes, such as the bacteria Vibrio vulnificus and Yersinia enterocolitica 62, 63, 64.”
  • In mouse infection models, iron's importance has been supported for Vibrio vulnificus and nonpigmented Yersinia pestis plague vaccine strains.

    “The importance of iron has been corroborated in mouse models of infection by Vibrio vulnificus and nonpigmented Y. pestis (plague vaccine strains) (112, 146).”

    From Transition Metals and Virulence in Bacteria (2016) · cites this paper as [112]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 39

  1. Yersin A. La peste bubonique à Hong-Kong. Ann Inst Pasteur 1894; 2:428-30.
  2. Bos KI, Schuenemann VJ, Golding GB, et al. A draft genome of Yersi- nia pestis from victims of the black death. Nature 2011; 478:506-10.
  3. Simond PL. La propagation de la peste. Ann Inst Pasteur 1898; 12:625-87.
  4. Meyer KF. Effectiveness of live or killed plague vaccines in man. Bull World Health Organ 1970; 42:653-66.
  5. Girard G. Plague. Annu Rev Microbiol 1955; 9:253-77.
  6. Burrows TW. An antigen determining virulence in Pasteurella pestis. Nature 1956; 177:426-7.
  7. Marketon MM, DePaolo RW, DeBord KL, Jabri B, Schneewind O. Plague bacteria target immune cells during infection. Science 2005; 309:1739-41.
  8. Mueller CA, Broz P, Muller SA, et al. The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles. Science 2005; 310:674-6.
  9. Quenee L, Cornelius CA, Ciletti NA, Elli D, Schneewind O. Yersinia pestis caf1 (F1) variants and the limits of plague vaccine protection. Infect Immun 2008; 76:2025-36.
  10. Cornelius CA, Quenee LE, Elli D, Ciletti NA, Schneewind O. Yersinia pestis IS1541 transposition provides for escape from plague immunity. Infect Immun 2009; 77:1807-16.
  11. Fetherston JD, Schuetze P, Perry RD. Loss of the pigmentation pheno- type in Yersinia pestis is due to the spontaneous deletion of 102 kb of chromosomal DNA which is flanked by a repetitive element. Mol Microbiol 1992; 6:2693-704.
  12. Buchrieser C, Rusniok C, Frangeul L, et al. The 102-kilobase pgm locus of Yersinia pestis: sequence analysis and comparison of selected regions among different Yersinia pestis and Yersinia pseudotuberculo- sis strains. Infect Immun 1999; 67:4851-61.
  13. Bearden S, Fetherston J, Perry R. Genetic organization of the yersinia- bactin biosynthetic region and construction of avirulent mutants in Yersinia pestis. Infect Immun 1997; 65:1659-68.
  14. Gehring AM, DeMoll E, Fetherston JD, et al. Iron acquisition in plague: modular logic in enzymatic biogenesis of yersiniabactin by Yersinia pestis. Chem Biol 1998; 5:573-86.
  15. Quenee LE, Ciletti NA, Elli D, Hermanas T, Schneewind O. Preven- tion of pneumonic plague in mice, rats, guinea pigs and non-human primates with clinical grade rV10, rV10-2 or F1-V vaccines. Vaccine 2011; 29:6572-83.
  16. DeBord KL, Anderson DM, Marketon MM, et al. Immunogenicity and protective immunity against bubonic and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV. Infect Immun 2006; 74:4910-4.
  17. Brubaker RR. Mutation rate to non-pigmentation in Pasteurella pestis. J Bacteriol 1969; 98:1404-6.
  18. Overheim KA, Depaolo RW, Debord KL, et al. LcrV plague vaccine with altered immunomodulatory properties. Infect Immun 2005; 73:5152-9.
  19. Jackson S, Burrows TW. The virulence enhancing effect of iron on non-pigmented mutants of virulent strains of Pasteurella pestis. Brit J Exp Pathol 1956; 37:570-6.
  20. Galvan EM, Nair MK, Chen H, Del Piero F, Schifferli DM. Biosafety level 2 model of pneumonic plague and protection studies with F1 and Psa. Infect Immun 2010; 78:3443-53.
  21. Robins-Browne RM, Prpic JK. Effects of iron and desferrioxamine on infections with Yersinia enterocolitica. Infect Immun 1985; 47:774-9.
  22. Huang FW, Pinkus JL, Pinkus GS, Fleming MD, Andrews NC. A mouse model of juvenile hemochromatosis. J Clin Invest 2005; 115:2188-91.
  23. Motin VM, Nedialkov YA, Brubaker RR. V antigen-polyhistidine fusion peptide: binding to LcrH and active immunity against plague. Infect Immun 1996; 64:4313-8.
  24. Perry RD, Harmon PA, Bowmer WS, Straley SC. A low-Ca 2+ response operon encodes the V antigen of Yersinia pestis. Infect Immun 1986; 54:428-34.
  25. Quenee LE, Berube B, Segal J, et al. Amino acid residues 196-225 of LcrV represent a plague protective epitope. Vaccine 2010; 28:1870-6.
  26. DePaolo RW, Tang F, Kim IY, et al. TLR6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis. Cell Host Microbe 2008; 4:350-61.
  27. Andrews NC. Forging a field: the golden age of iron biology. Blood 2008; 112:219-30.
  28. Feder JN, Gnirke A, Thomas W, et al.. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13:399-408.
  29. Camaschella C, Roetto A, Cali A, et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 2000; 25:14-5.
  30. Montosi G, Donovan A, Totaro A, et al. Autosomal-dominant hemo- chromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 2001; 108:619-23.
  31. Roetto A, Papanikolaou G, Politou M, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 2002; 33:21-2.
  32. Nicolas G, Bennoun M, Porteu A, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci U S A 2002; 99:4596-601.
  33. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004; 306:2090-3.
  34. Beutler E. Penetrance of hemochromatosis. Gut 2003; 52:610-1.
  35. Ajioka RS, Kushner JP. Clinical consequences of iron overload in he- mochromatosis homozygotes. Blood 2003; 101:3351-3.
  36. Jouanolle AM, Fergelot P, Gandon G, Yaouanq J, Le Gall JY, David V. A candidate gene for hemochromatosis: frequency of the C282Y and H63D mutations. Hum Genet 1997; 100:544-7.
  37. Tolosano E, Fagoonee S, Garuti C, et al. Haptoglobin modifies the he- mochromatosis phenotype in mice. Blood 2005; 105:3353-5.
  38. Moalem S, Percy ME, Kruck TP, Gelbart RR. Epidemic pathogenic selection: an explanation for hereditary hemochromatosis? Med Hypotheses 2002; 59:325-9.
  39. Paradkar PN, De Domenico I, Durchfort N, Zohn I, Kaplan J, Ward DM. Iron depletion limits intracellular bacterial growth in macrophag- es. Blood 2008; 112:866-74.

Cited by

Sorted by citations

Authors
Quenee, L. E., Hermanas, T. M., Ciletti, N., Louvel, H., Miller, N. C., Elli, D., Blaylock, B., Mitchell, A., Schroeder, J., Krausz, T., Kanabrocki, J., & Schneewind, O.
Affiliations
  • Argonne National Laboratory (US)
  • University of Chicago (US)
Corresponding author
Quenee, L. E.
Venue
Journal of Infectious Diseases
Published
2012-08-14
Volume
206
Issue
7
Pages
1050-1058
ISSN
  • 0022-1899 (ISSN-L)
  • 1537-6613
OpenAlex
W2170242329
Cited by
65
References
7
Citations by year
2026: 2 · 2025: 3 · 2024: 6 · 2023: 2 · 2022: 5 · 2021: 12 · 2020: 3 · 2019: 8 · 2018: 3 · 2017: 3 · 2016: 5 · 2015: 7 · 2014: 3 · 2013: 2 · 2012: 1
FWCI
2.51
Type
journal article
Language
en
Open access
Locations
  • The Journal of Infectious Diseases (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Allergy and Infectious Diseases (U54AI057153)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Yersinia bacterium, plague, ectoparasites research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacillus and Francisella bacterial research
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
Keywords
hereditary hemochromatosis, Yersinia pestis, plague, iron storage, iron acquisition, subunit vaccine, type III secretion system, vaccine safety
MeSH terms
Hemochromatosis Protein, Animals, Female, Hemochromatosis, Liver, Membrane Proteins, Plague, Plague Vaccine, Spleen, Vaccines, Attenuated, Virulence, Yersinia pestis, Mice, Knockout, Vaccines, Subunit, Microbial Viability, Mice, Mice, 129 Strain, GPI-Linked Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review